NBP NOVABRIDGE BIOSCIENCES revenue, earnings and financials
For the fiscal year ended December 2025 revenue was n/a.
NBP annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$94.3M, net income −$46.3M (margin n/a), EPS −$0.21
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$51.4M, net income −$22.2M (margin n/a), EPS −$0.12
- Fiscal year ended Dec 2023: revenue $632K, gross profit n/a, operating income −$72.0M, net income −$208M (margin -32868.5%), EPS −$1.09
- Fiscal year ended Dec 2022: revenue −$1.55M, gross profit n/a, operating income −$53.1M, net income −$371M (margin 23923.5%), EPS −$1.96
- Fiscal year ended Dec 2021: revenue $13.8M, gross profit n/a, operating income n/a, net income −$366M (margin -2648.7%), EPS −$2.09
NBP cash flow, buybacks and dividends
- Fiscal year ended Dec 2023: operating cash flow −$184M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$160M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$153M, share buybacks n/a
NBP balance sheet
- Dec 31, 2025: cash $211M, total assets $261M, total liabilities $29.6M, shareholders' equity $231M
- Jun 30, 2025: cash $165M, total assets $207M, total liabilities $9.98M, shareholders' equity $197M
- Dec 31, 2024: cash $68.3M, total assets $213M, total liabilities $11.5M, shareholders' equity $201M
- Dec 31, 2023: cash $292M, total assets $369M, total liabilities $126M, shareholders' equity $243M
- Dec 31, 2022: cash $343M, total assets $591M, total liabilities $169M, shareholders' equity $418M
- Jun 30, 2022: cash $554M, total assets $745M, total liabilities $146M, shareholders' equity $600M
- Dec 31, 2021: cash $553M, total assets $879M, total liabilities $163M, shareholders' equity $715M
Is NBP profitable?
No. NOVABRIDGE BIOSCIENCES lost $46.3M in its latest fiscal year.